Tag archive for ‘OTCMKTS:BIEL’
bioelectronics-corp
By Justin Orwell On Thursday, March 2nd, 2017
1 Comment

Bioelectronics Corp (OTCMKTS:BIEL) ActiPatch Study Issued In The Pain Management Medical Journal

Bioelectronics Corp (OTCMKTS:BIEL) the firm that manufactures ActiPatch® reported that its OTC central sensitization treatment was covered in a Pain Management Medical publication. The article focused on the chronic More...

By Robert Townsend On Wednesday, February 22nd, 2017
0 Comments

Bioelectronics Corp (OTCMKTS:BIEL) Brings ActiPatch To The US Market

Bioelectronics Corp (OTCMKTS:BIEL) has announced that its ActiPatch Musculoskeletal Pain Therapy devices, are now available on Amazon.com, for the US market. The product has been quite popular in the UK, getting More...

bioelectronics-corp
By kunal sharma On Tuesday, February 14th, 2017
0 Comments

What may be next from Bioelectronics Corp (OTCMKTS:BIEL)?

There hasn’t been much development around Bioelectronics Corp (OTCMKTS:BIEL) stock for the entire month that’s gone by. The share kept revolving around a rate of $0.0003 a share. But, with the onset of February, More...

bioelectronics-corp
By Jasmine Hathaway On Friday, February 10th, 2017
0 Comments

Bioelectronics Corp (OTCMKTS:BIEL)’s ActiPatch Available on Amazon

Bioelectronics Corp (OTCMKTS:BIEL) the manufacturer of advanced pain management medical equipments reported that ActiPatch® is now available on the United States Amazon.com. ActiPatch is the major nonprescription More...

Bioelectronics Corp
By Jasmine Hathaway On Thursday, December 22nd, 2016
0 Comments

Bioelectronics Corp (OTCMKTS:BIEL) ActiPatch Nonprescription Medical Device Minimizes Pain 52%

Bioelectronics Corp (OTCMKTS:BIEL) the manufacturer of ActiPatch®, an advanced OTC medical device, reported the publication of a clinical trial. The report suggested that ActiPatch® treatment is effective for More...

By Robert Townsend On Friday, December 9th, 2016
0 Comments

Bioelectronics Corp (OTCMKTS:BIEL) Speaks On OTC Market Clearance Application

Bioelectronics Corp (OTCMKTS:BIEL) the maker of unique disposable electroceutical devices, reported that they met with senior management from the U.S. FDA’s segment of Neurological and Physical Medicine Devices, More...

bioelectronics-corp
By Joshua Westerland On Tuesday, November 22nd, 2016
0 Comments

Bioelectronics Corp (OTCMKTS:BIEL) Engages Southeast Asia Distributor

Bioelectronics Corp (OTCMKTS:BIEL) has appointed engaged PharmEvo as its ‘ActiPatch®’ Musculoskeletal Pain Therapy supplier for Cambodia, Myanmar, Vietnam, Sri Lanka and Kenya. PharmEvo, established in 1999, More...

By Robert Townsend On Wednesday, September 14th, 2016
0 Comments

Bioelectronics Corp (OTCMKTS:BIEL) To Introduce ActiPatch In Sweden

Bioelectronics Corp (OTCMKTS:BIEL) has announced that it has launched its ActiPatch musculoskeletal pain therapy in Sweden. The launch had been made possible with the help of the company’s distributor in Sweden, More...

By Jasmine Hathaway On Wednesday, June 29th, 2016
0 Comments

Bioelectronics Corp (OTCMKTS:BIEL) Aims To Pursue 510(k) Path For ActiPatch

Bioelectronics Corp (OTCMKTS:BIEL) has provided an update on its official company website, stating that a representative from the US FDA had met with the company and updated that the 510(k) pathway might now be More...

By Justin Orwell On Tuesday, August 26th, 2014
0 Comments

Bioelectronics Corp (OTCMKTS:BIEL): Reports Successful Results from 7-day ActiPatch Sample Program

Bioelectronics Corp (OTCMKTS:BIEL) today released its updated statistics for the seven days ‘Try It and Tell Us’ ActiPatch sample program for the U.K. and Ireland residents. The company noted 77 percent efficacy More...